BARDA
Funding rounds backed by BARDA.
- Funding disclosed in full
- $60M
- Median round
- $60M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Vedanta Biosciences Develops microbiome-based oral therapies for prevention of recurrent C. difficile infection | $60MGrowth | BiotechUnited States |